doctoral candidate
Russian Federation
A new method of self-control of diabetes based on the results of continuous monitoring of glycemia (HMG) is especially relevant in patients who are on pump insulin therapy, especially since the start of pump insulin therapy is carried out with the mandatory installation of the HMG system [1,3]. Due to the novelty of these two methods (treatment of diabetes and control of glycemia) for a wide clinical practice, there is an urgent need to publish concise practical guides on this topic for doctors, both for self-study of these methods, and for advanced training courses. Based on the above and our experience of teaching at the Department of Endocrinology of the Federal Medical University of MONICA, this guide has been prepared, which will be useful, first of all, for endocrinologists, therapists working with patients with diabetes, as well as for senior students of medical institutes who are interested in new directions in practical medicine.
blood glucose, insulin therapy, diabetes, treatment of diabetes, endocrinologist, therapist
Полный текст монографии доступен в формате электронной книги.
Ссылки на скачивание размещены здесь https://aegitas.ru/books/656697/
1. Barsukov I. A., Demina A. A. New technologies in the management of diabetes mellitus: from theory to practice. // Consilium medicum. 2018. No. 20 (4) p. 24-28.
2. Dreval A.V. Pump insulin therapy and continuous monitoring of glycemia (clinical practice and prospects) / / GEOTAR-Media. 2020. 336 p.
3. Dreval A.V. Diabetological practice. Geotar-Media, 2018. 544 p.
4. Dreval A.V., Dreval O. A. Physical activity and diabetes mellitus. The manual. GEOTAR-Media. 2020. 352 p.
5. Shestakova M. V., Mayorov A. Yu., Fillipov Yu. I., Ibragimova L. I., Pekareva E. V., Laptev D. N., Glazunova A.M. Federal clinical recommendations for pump insulin therapy and continuous monitoring of glycemia in patients with diabetes mellitus. Problems of endocrinology. 2015. No. 6. pp. 56 - 78.
6. Aronson R. et al. OpT2mise: A randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes. // Diabetes Technol Ther. 2014. Vol. 16. p.414 - 420.
7. American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force consensus statement. // Endocrine Practice. 2014. Vol.20. p.462 - 489.
8. Batellino T. et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. // Diabetologia. 2012. p. 3155 - 62.
9. Beato-Vibora P, Yeoh E, Rogers H et al. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes. // Diabet Med. 2015. Vol.32. p.1453 - 9.
10. Bell KJ, Smart CE, Steil GM et al. Impact of fat, protein, and glycemic index on postprandial glucose control in Type 1 Diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. // Diabetes Care. 2015. Vol.38. p.1008-1015
